The CD73-positive MSCs could be seen to proliferate more than the CD73- negative MSCs, and to have a higher potential to differentiate into different cell types, indicating that this group of MSCs may be particularly effective for bone repair. The researchers therefore went on to study the functions of these CD73-positive MSCs in fracture healing.
Regenerative medicine is an upcoming field of medical science. There are rapid advancements, with techniques, protocols and equipment evolving and changing almost every day. Bringing the latest advances into India requires a lot of funding.
This acquisition marks Laurus Labs’ entry into the broader biologics and biotechnology segments, providing the company access to its high growth areas, globally and in India.
The company now plans to commercialise Stempeucel for the same indication in Japan in partnership with Novumcella, the statement said.
The facilities will serve CollPlant for the development of its products, including BioInks for 3D bioprinting of tissues and organs, and dermal fillers for medical aesthetics, the company said on Wednesday.
Regenerative medicine is the most recent advancement in medical treatment, offering novel therapeutic approaches to replace or restore the original functions of tissues, functional systems or even entire organs.
According to ICMR’s deputy director general Dr Geeta Jotwani, the final document on Stem Cell Research Guidelines 2017 will soon be launched by the Union Ministry of Health and Family Welfare.
There is increasing awareness amongst clinicians who now more receptive to and are advising cell based therapy as an effective therapeutic modality for treatment of diseases.
Researchers at Karolinska Institutet have identified cell surface markers specific for the very earliest stem cells in the human embryo.
Researchers for the first time showed how 'click-chemistry' can be used to attach molecules, such as antibiotics or fluorescent dyes, to artificially produced spider silk synthesised by E coli bacteria.
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
